US Patent 7393862 Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
Patent 7393862 was granted and assigned to Celgene on July, 2008 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7393862 Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
